These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7352599)

  • 1. Cholinergic rebounds and withdrawal syndromes.
    Pary RJ; Klontz W; Foxworth JM
    Am J Psychiatry; 1980 Feb; 137(2):261. PubMed ID: 7352599
    [No Abstract]   [Full Text] [Related]  

  • 2. Cholinergic rebound in neuroleptic withdrawal syndromes.
    Lieberman J
    J Clin Psychiatry; 1981 Apr; 42(4):179. PubMed ID: 6110656
    [No Abstract]   [Full Text] [Related]  

  • 3. Cholinergic syndrome from psychotropic withdrawal in a marijuana abuser.
    Dilsaver SC; Leckrone J; Greden JF
    Psychosomatics; 1984 Aug; 25(8):632-4. PubMed ID: 6332335
    [No Abstract]   [Full Text] [Related]  

  • 4. Cholinergic syndrome following anticholinergic withdrawal in a schizophrenic patient abusing marijuana.
    Tandon R; Dutchak D; Greden JF
    Br J Psychiatry; 1989 May; 154():712-4. PubMed ID: 2597866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concurrent haloperidol withdrawal and benztropine overdose: a case report.
    West RR; Newgreen DB
    Compr Psychiatry; 1978; 19(6):557-60. PubMed ID: 720041
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of cholinergic supersensitivity in the medical symptoms associated with withdrawal of antipsychotic drugs.
    Luchins DJ; Freed WJ; Wyatt RJ
    Am J Psychiatry; 1980 Nov; 137(11):1395-8. PubMed ID: 6108078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticholinergic equivalents and parkinsonism: a model for predicting side-effects of antipsychotic drugs.
    Menkes DB; Clarkson HO; Caradoc-Davies G; Mullen PE
    Int Clin Psychopharmacol; 1987 Jan; 2(1):55-67. PubMed ID: 2889760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Editorial: Physostigmine: value in treatment of central toxic effects of anti-cholinergic drugs.
    Hussey HH
    JAMA; 1975 Mar; 231(10):1066. PubMed ID: 1172797
    [No Abstract]   [Full Text] [Related]  

  • 9. Protracted vomiting following abrupt cessation of psychotropics: a case report.
    Kalman T; Warner GM
    Can Psychiatr Assoc J; 1978 Apr; 23(3):163-5. PubMed ID: 647615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delirium after abrupt withdrawal from doxepin: case report.
    Santos AB; Mccurdy L
    Am J Psychiatry; 1980 Feb; 137(2):239-40. PubMed ID: 7352585
    [No Abstract]   [Full Text] [Related]  

  • 11. Withdrawal dyskinesia after abrupt cessation of clozapine and benztropine.
    Songer DA; Schulte HM
    J Clin Psychiatry; 1996 Jan; 57(1):40. PubMed ID: 8543548
    [No Abstract]   [Full Text] [Related]  

  • 12. Doxepin withdrawal mania.
    Galynker II; Rosenthal RN; Perkel C; Shwartz A
    J Clin Psychiatry; 1995 Mar; 56(3):122-3. PubMed ID: 7883732
    [No Abstract]   [Full Text] [Related]  

  • 13. Physostigmine. Its use in acute anticholinergic syndrome with antidepressant and antiparkinson drugs.
    Granacher RP; Baldessarini RJ
    Arch Gen Psychiatry; 1975 Mar; 32(3):375-80. PubMed ID: 1115577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cerebral seizures under doxepin during a substitution with dihydrocodeine].
    Ulmer A
    Dtsch Med Wochenschr; 1994 Sep; 119(37):1260. PubMed ID: 7924915
    [No Abstract]   [Full Text] [Related]  

  • 15. Alcohol, acetaldehyde and salsolinol-induced alterations in function and metabolism of cerebral GABAergic and cholinergic neurons: possible involvements in alcohol dependence and withdrawal.
    Kuriyama K; Ohkuma S; Taguchi J; Hashimoto T
    Prog Clin Biol Res; 1987; 241():271-82. PubMed ID: 3039531
    [No Abstract]   [Full Text] [Related]  

  • 16. A case of withdrawal dyskinesia.
    Gardos G
    Am J Psychiatry; 1979 Aug; 136(8):1099. PubMed ID: 464147
    [No Abstract]   [Full Text] [Related]  

  • 17. [Central anticholinergic intoxication syndrome. A contribution to the differential diagnosis of exogenous psychoses].
    Kastrup O; Eikmeier G; Gastpar M
    Dtsch Med Wochenschr; 1991 Nov; 116(46):1748-51. PubMed ID: 1935662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haloperidol and benztropine in rapid neuroleptization.
    Evans L
    Med J Aust; 1978 May; 1(10):567-8. PubMed ID: 683069
    [No Abstract]   [Full Text] [Related]  

  • 19. Anticholinergic psychosis in a patient receiving usual doses of haloperidol, desipramine, and benztropine.
    Hvizdos AJ; Bennett JA; Wells BG; Rappaport KB; Mendel SA
    Clin Pharm; 1983; 2(2):174-8. PubMed ID: 6883947
    [No Abstract]   [Full Text] [Related]  

  • 20. Phobic behavior after haloperidol withdrawal.
    Mizes JS
    Am J Psychiatry; 1984 Apr; 141(4):612. PubMed ID: 6703151
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.